Article Details

Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment ...

Retrieved on: 2021-06-24 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Pieris Pharmaceuticals Receives Orphan Drug Designation for Cinrebafusp Alfa for the Treatment .... View article details on HISWAI: https://www.biospace.com/article/releases/pieris-pharmaceuticals-receives-orphan-drug-designation-for-cinrebafusp-alfa-for-the-treatment-of-gastric-cancer/

Excerpt

(NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up